StonvexLoading…
StonvexStonvexStonvexCore line items from MMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.34B | $2.65B | $1.35B | $5.43B | $4.11B |
Operating Income | Not available | $294.70M | $146.21M | $528.29M | $405.43M |
Net Income | Not available | $192.01M | $93.94M | $319.03M | $243.75M |
EPS (Diluted) | $2.27 | $3.50 | $1.70 | $5.51 | $4.20 |
Total Assets | Not available | $4.24B | $4.21B | $4.07B | $4.46B |
Total Liabilities | Not available | $2.54B | $2.49B | $2.40B | $2.69B |
Cash & Equivalents | Not available | $157.45M | $137.59M | $222.35M | $59.78M |
Free Cash Flow OCF − CapEx | Not available | $-71.65M | $-250.66M | $366.16M | $-275.69M |
Shares Outstanding | Not available | 53.11M | 54.55M | 54.80M | 56.35M |